Induction chemoterapy gemcitabine(G)-cisplatin(C) versus etoposide(E)-cisplatin(C) in IIIA/IIIB stages non — small cell lung cancer (NSCLC) patients with intermittent radiotherapy... von Cicenas, Saulius, Pipiriene-Zelviene, Terese, Burneckis, Arvydas, Ciceniene, Audrone

Volltext

Targeted therapy in patients with non-small cell lung cancer previously treated with chemotherapy von Drobnienė, Monika, Cicėnienė, Audronė, Zelvienė, Teresė Pipirienė, Grigienė, Rūta, Lachej, Nadežda, Steponavičienė, Laura, Aleknavičius, Eduardas

Volltext

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial von Baselga, José, Dr, Bradbury, Ian, PhD, Eidtmann, Holger, MD, Di Cosimo, Serena, MD, de Azambuja, Evandro, MD, Aura, Claudia, MD, Gómez, Henry, MD, Dinh, Phuong, MD, Fauria, Karine, PhD, Van Dooren, Veerle, MSc, Aktan, Gursel, MD, Goldhirsch, Aron, MD, Chang, Tsai-Wang, MD, Horváth, Zsolt, MD, Coccia-Portugal, Maria, MD, Domont, Julien, MD, Tseng, Ling-Min, MD, Kunz, Georg, MD, Sohn, Joo Hyuk, MD, Semiglazov, Vladimir, MD, Lerzo, Guillermo, MD, Palacova, Marketa, MD, Probachai, Volodymyr, MD, Pusztai, Lajos, DPhil, Untch, Michael, PhD, Gelber, Richard D, PhD, Piccart-Gebhart, Martine, PhD

Volltext